Malin Corporation | MLC - Net Income

Stock Price
7.45
Daily Change
-0.15 -1.97%
Monthly
-6.88%
Yearly
-12.35%
Q2 Forecast
7.23

Malin Corporation reported EUR-1.1M in Net Income for its fiscal semester ending in December of 2023.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
ALKERMES USD -66.48M 115.82M Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Eurofins Scientific SE EUR 193.7M 22.3M Dec/2025
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Lonza CHF 426M 119M Jun/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD -205M 365M Dec/2025
Ovoca Bio EUR -765K 4.89M Jun/2025
Revvity USD 40.72M 57.65M Mar/2026
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025